United States · FDA National Drug Code directory
BONJESTA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55494-120_3e4fbcb3-ac64-4673-b46f-a2ce616d4374
- Product NDC
- 55494-120
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- doxylamine succinate and pyridoxine hydrochloride
- Labeler
- Duchesnay USA, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180219
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXYLAMINE SUCCINATE — 20 mg/1
- PYRIDOXINE HYDROCHLORIDE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (55494-120-10) · 55494-120-10
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (55494-120-60) · 55494-120-60
- 1 BLISTER PACK in 1 CARTON (55494-120-94) / 4 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 55494-120-94
- 6 TABLET, EXTENDED RELEASE in 1 BOTTLE (55494-120-99) · 55494-120-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →